Bill > HR1563

This bill, known as the "Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act" or the "STOP Fentanyl and Xylazine Act", amends the Controlled Substances Act to explicitly clarify that drug testing equipment designed to detect the presence of fentanyl or xylazine is not considered unlawful. Specifically, the bill modifies Section 422 of the Controlled Substances Act by adding a new subsection that exempts drug testing equipment from existing legal restrictions that might otherwise prohibit possession, sale, purchase, importation, exportation, or transportation of such equipment. This legislative change is significant because it removes potential legal barriers to obtaining and using testing tools that can help identify dangerous synthetic drugs like fentanyl and xylazine, which are increasingly involved in overdose deaths. By making this clarification, the bill aims to support harm reduction efforts and potentially help prevent accidental drug overdoses by making it easier for individuals and organizations to test for the presence of these potent substances.

Justice

https://www.congress.gov/bill/119th-congress/house-bill/1563/all-info